To explore the predictive value of the Thompson score during the first 4 days of life for estimating short-term adverse outcomes in neonatal encephalopathy.
This observational study evaluated infants with neonatal encephalopathy (≥36 weeks of gestation) registered in a multicenter cohort of cooled infants in Japan. The Thompson score was evaluated at 0–24, 24–48, 48–72, and 72–90 h of age. Adverse outcomes included death, survival with respiratory impairment (requiring tracheostomy), or survival with feeding impairment (requiring gavage feeding) at discharge.
Of the 632 infants, 21 (3.3%) died, 59 (9.3%) survived with respiratory impairment, and 113 (17.9%) survived with feeding impairment. The Thompson score throughout the first 4 days accurately predicted death, respiratory impairment, or feeding impairment. The 72–90 h score showed the highest accuracy. A cutoff of ≥15 had a sensitivity of 0.85 and specificity of 0.92 for death or respiratory impairment, while a cutoff of ≥14 had a sensitivity of 0.71 and a specificity of 0.92 for death, respiratory or feeding impairment.
A high Thompson score during the first 4 days of life, especially at 72–90 h could thus be useful for estimating the need for prolonged life support.
The Thompson score on days 1–4 of age was useful in predicting death and respiratory or feeding impairments. The 72–90 h Thompson score showed the highest predictive capability.
Owing to the rarity of withdrawal of life-sustaining treatment in Japan, 43% of infants with persistent severe encephalopathy with a Thompson score of ≥15 at 72–90 h of age could regain spontaneous breathing, be extubated, and survive without tracheostomy. Meanwhile, approximately 50% of infants who survived without tracheostomy required gavage feeding.
Our results could provide useful information for clinical decision making regarding infants with persistent severe encephalopathy.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 13 print issues and online access
$259.00 per year
only $19.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
Jacobs, S. E. et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst. Rev. 2013, CD003311 (2013).
Massaro, A. N. et al. Short-term outcomes after perinatal hypoxic ischemic encephalopathy: a report from the Children’s Hospitals Neonatal Consortium Hie Focus Group. J. Perinatol. 35, 290–296 (2015).
Tsuda, K. et al. Therapeutic hypothermia for neonatal encephalopathy: a report from the first 3 years of the Baby Cooling Registry of Japan. Sci. Rep. 7, 39508 (2017).
Westwood, E. L., Hutchins, J. V. & Thevasagayam, R. Quality of life in paediatric tracheostomy patients and their caregivers – a cross-sectional study. Int J. Pediatr. Otorhinolaryngol. 127, 109606 (2019).
Natarajan, G. et al. Withdrawal of life-support in neonatal hypoxic-ischemic encephalopathy. Pediatr. Neurol. 91, 20–26 (2019).
Lemmon, M. E. et al. Ethical considerations in the care of encephalopathic neonates treated with therapeutic hypothermia. Semin. Fetal Neonatal Med. 26, 101258 (2021).
Wilkinson, D. The window of opportunity for treatment withdrawal. Arch. Pediatr. Adolesc. Med. 165, 211–215 (2011).
Racine, E. & Shevell, M. I. Ethics in neonatal neurology: when is enough, enough? Pediatr. Neurol. 40, 147–155 (2009).
Shankaran, S. et al. Evolution of encephalopathy during whole body hypothermia for neonatal hypoxic-ischemic encephalopathy. J. Pediatr. 160, 567–572.e563 (2012).
Morales, M. M. et al. Association of Total Sarnat Score with brain injury and neurodevelopmental outcomes after neonatal encephalopathy. Arch. Dis. Child Fetal Neonatal Ed. 106, 669–672 (2021).
Thompson, C. M. et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 86, 757–761 (1997).
Weeke, L. C. et al. A novel magnetic resonance imaging score predicts neurodevelopmental outcome after perinatal asphyxia and therapeutic hypothermia. J. Pediatr. 192, 33–40.e32 (2018).
Lally, P. J. et al. Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study. Lancet Neurol. 18, 35–45 (2019).
Del Rio, R. et al. Amplitude integrated electroencephalogram as a prognostic tool in neonates with hypoxic-ischemic encephalopathy: a systematic review. PLoS One 11, e0165744 (2016).
Mendler, M. R. et al. Predictive value of thompson-score for long-term neurological and cognitive outcome in term newborns with perinatal asphyxia and hypoxic-ischemic encephalopathy undergoing controlled hypothermia treatment. Neonatology 114, 341–347 (2018).
Murray, D. M. et al. The predictive value of early neurological examination in neonatal hypoxic-ischaemic encephalopathy and neurodevelopmental outcome at 24 months. Dev. Med. Child Neurol. 52, e55–e59 (2010).
Committee on Fetus and Newborn et al. Hypothermia and neonatal encephalopathy. Pediatrics 133, 1146–1150 (2014).
Sarnat, H. B. & Sarnat, M. S. Neonatal encephalopathy following fetal distress: a clinical and electroencephalographic study. Arch. Neurol. 33, 696–705 (1976).
Shibasaki, J. et al. Outcomes related to 10-min Apgar scores of zero in Japan. Arch. Dis. Child Fetal Neonatal Ed. 105, 64–68 (2020).
Eventov-Friedman, S., Kanevsky, H. & Bar-Oz, B. Neonatal end-of-life care: a single-center NICU experience in israel over a decade. Pediatrics 131, e1889–e1896 (2013).
Verhagen, A. A., Dorscheidt, J. H., Engels, B., Hubben, J. H. & Sauer, P. J. End-of-life decisions in Dutch neonatal intensive care units. Arch. Pediatr. Adolesc. Med. 163, 895–901 (2009).
Yotani, N. et al. Withholding and withdrawal of life-sustaining treatments for neonate in Japan: are hospital practices associated with physicians’ beliefs, practices, or perceived barriers? Early Hum. Dev. 141, 104931 (2020).
Shipley, L., Gale, C. & Sharkey, D. Trends in the incidence and management of hypoxic-ischaemic encephalopathy in the therapeutic hypothermia era: a national population study. Arch. Dis. Child Fetal Neonatal Ed. 106, 529–534 (2021).
Shibasaki, J. et al. Comparison of predictive values of magnetic resonance biomarkers based on scan timing in neonatal encephalopathy following therapeutic hypothermia. J. Pediatr. 239, 101–109.e4 (2021).
Martinez-Biarge, M. et al. Feeding and communication impairments in infants with central grey matter lesions following perinatal hypoxic-ischaemic injury. Eur. J. Paediatr. Neurol. 16, 688–696 (2012).
Martinez-Biarge, M., Diez-Sebastian, J., Rutherford, M. A. & Cowan, F. M. Outcomes after central grey matter injury in term perinatal hypoxic-ischaemic encephalopathy. Early Hum. Dev. 86, 675–682 (2010).
Gupta, S. et al. Predicting the need for home gavage or G-tube feeds in asphyxiated neonates treated with therapeutic hypothermia. J. Perinatol. 38, 728–733 (2018).
Berube, M. W. et al. Opioid and benzodiazepine use during therapeutic hypothermia in encephalopathic neonates. J. Perinatol. 40, 79–88 (2020).
The authors are grateful to the staff of participating centers for their contribution to the data collection, and the infants and their parents for sharing the clinical information.
The study was supported by the Japan Society for the Promotion of Science KAKENHI (Grant Number JP20K08247).
The authors declare no competing interests.
Ethics approval and consent to participate
This study was approved by the Ethics Committees of the Kurume University School of Medicine and Saitama Medical University, Japan, and was conducted in compliance with the principles of the Declaration of Helsinki. The need for parental consent was waived because no identifying information was collected.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Aoki, H., Shibasaki, J., Tsuda, K. et al. Predictive value of the Thompson score for short-term adverse outcomes in neonatal encephalopathy. Pediatr Res 93, 1057–1063 (2023). https://doi.org/10.1038/s41390-022-02212-7